Portal de investigação
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
Autores da FMUP
Participantes de fora da FMUP
- Monzo, L
- Girerd, N
- Lamiral, Z
- Anker, SD
- Cleland, JGF
- Kondo, T
- Mcmurray, JJV
- Lam, CSP
- Mehra, MR
- Veldhuisen, DJV
- Greenberg, B
- Zannad, F
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Citar a publicação
Monzo L,Girerd N,Ferreira JP,Lamiral Z,Anker SD,Cleland JGF,Kondo T,Mcmurray JJV,Lam CSP,Mehra MR,Veldhuisen DJV,Greenberg B,Zannad F. High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial. J. Card. Fail. 2024. 30. (4):p. 618-623. IF:6,000. (1).
